» Articles » PMID: 17911135

Chlamydia Trachomatis Seroprevalence Atlas of Finland 1983-2003

Overview
Date 2007 Oct 4
PMID 17911135
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Objectives: To study Chlamydia trachomatis seroprevalence trends and geographical distribution over time in Finland.

Materials And Methods: First pregnancy serum samples were retrieved from the Finnish Maternity Cohort serum bank for the subcohort of 8000 women stratified by calendar years (1983-1989, 1990-1996, 1997-2003) and age at time of sample withdrawal (14-22 and 23-28 years). C trachomatis antibodies were determined using standard major outer membrane protein peptide ELISA. The spatiotemporal variation of C trachomatis seroprevalence rates was visualised by a series of maps.

Results: A decreasing C trachomatis seroprevalence trend from 1983 to 2003 was seen for both women under 23 years of age (20.8% to 10.6%) and 23-28-year-old women (19.1% to 12.5%). Constant clusters were seen around the largest cities and in eastern Finland although seroprevalence rates were generally decreasing throughout the country.

Conclusions: Only a few population-based serological studies have been undertaken on C trachomatis epidemiology over time. In Finland the seroprevalence of C trachomatis is decreasing all over the country, albeit with small clusters remaining.

Citing Articles

Trends in IgG seroprevalence in the general population of the Netherlands over 20 years.

Alexiou Z, van Aar F, Hoenderboom B, Morre S, Heijne J Sex Transm Infect. 2023; 100(1):31-38.

PMID: 37985129 PMC: 10850662. DOI: 10.1136/sextrans-2023-055888.


Seroepidemiology of Infection in the General Population of Northern China: The Jidong Community Cohort Study.

Shui J, Xie D, Zhao J, Ao C, Lin H, Liang Y Front Microbiol. 2021; 12:729016.

PMID: 34650533 PMC: 8507574. DOI: 10.3389/fmicb.2021.729016.


Maternal Antibodies to Chlamydia trachomatis and Risk of Gastroschisis.

Parker S, Werler M, Gissler M, Surcel H Birth Defects Res. 2017; 109(8):543-549.

PMID: 28398639 PMC: 5901736. DOI: 10.1002/bdr2.1001.


Defining Seropositivity Thresholds for Use in Trachoma Elimination Studies.

Migchelsen S, Martin D, Southisombath K, Turyaguma P, Heggen A, Rubangakene P PLoS Negl Trop Dis. 2017; 11(1):e0005230.

PMID: 28099433 PMC: 5242428. DOI: 10.1371/journal.pntd.0005230.


Chlamydia trachomatis Pgp3 Antibody Persists and Correlates with Self-Reported Infection and Behavioural Risks in a Blinded Cohort Study.

Horner P, Wills G, Righarts A, Vieira S, Kounali D, Samuel D PLoS One. 2016; 11(3):e0151497.

PMID: 26974653 PMC: 4790965. DOI: 10.1371/journal.pone.0151497.